AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35078831 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue graft (CTG) combined with coronally advanced flap (CAF)
Number of subjects: 40
Study 34031695 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma containing neutralizing antibody to SARS-CoV-2
Number of subjects: 1274
Study 34031695 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild-type SARS-CoV-2 in seronegative individuals
Number of subjects: 1274
Study 34031695 — intervention group
Group type: EXPERIMENTAL
Intervention: B.1.1.7 variant
Number of subjects: 1274
Study 35152578 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with conventional ovulation induction protocol
Number of subjects: 60
Study 35152578 — intervention group
Group type: COMPARATOR
Intervention: Conventional ovulation induction protocol (Control group)
Number of subjects: 60
Study 34251406 — intervention group
Group type: EXPERIMENTAL
Intervention: High screen time (>2 hours per day)
Number of subjects: 414
Study 34251406 — intervention group
Group type: EXPERIMENTAL
Intervention: Television/computer in the bedroom (yes)
Number of subjects: 414
Study 34251406 — intervention group
Group type: COMPARATOR
Intervention: Low screen time (≤2 hours per day)
Number of subjects: 414
Study 34251406 — intervention group
Group type: COMPARATOR
Intervention: No television/computer in the bedroom
Number of subjects: 414
Study 33262937 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire-based pooling
Number of subjects: 25978
Study 33262937 — intervention group
Group type: COMPARATOR
Intervention: Random pooling
Number of subjects: 25978
Study 37380303 — intervention group
Group type: EXPERIMENTAL
Intervention: AF-CBT (n = 65)
Number of subjects: 127
Study 37380303 — intervention group
Group type: COMPARATOR
Intervention: Standardized AF education (n = 62)
Number of subjects: 127
Study 33622960 — intervention group
Group type: EXPERIMENTAL
Intervention: Male donor red blood cells (RBCs)
Number of subjects: 8850
Study 33622960 — intervention group
Group type: COMPARATOR
Intervention: Female donor red blood cells (RBCs)
Number of subjects: 8850
Study 32326727 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga therapy for 12 weeks
Number of subjects: 166
Study 32326727 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 166
Study 35125449 — intervention group
Group type: EXPERIMENTAL
Intervention: RIG 1 (POST group)
Number of subjects: 1100
Study 35125449 — intervention group
Group type: EXPERIMENTAL
Intervention: RIG 2 (POST group)
Number of subjects: 1100
Study 35125449 — intervention group
Group type: EXPERIMENTAL
Intervention: RIG implementation (POST group)
Number of subjects: 1100
Study 34408458 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV), 3 sessions a week for 8 weeks, in addition to the selected exercise program (balance exercises and resisted exercises)
Number of subjects: 38
Study 34408458 — intervention group
Group type: COMPARATOR
Intervention: Selected exercise program (balance exercises and resisted exercises)
Number of subjects: 38
Study 34697975 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough severity visual analog scale (VAS)
Number of subjects: 253
Study 34697975 — intervention group
Group type: COMPARATOR
Intervention: Cough Severity Diary (CSD)
Number of subjects: 253
Study 34697975 — intervention group
Group type: COMPARATOR
Intervention: Leicester Cough Questionnaire (LCQ)
Number of subjects: 253
Study 34697975 — intervention group
Group type: COMPARATOR
Intervention: Patient Global Impression of Change (PGIC) scale
Number of subjects: 253
Study 34697975 — intervention group
Group type: COMPARATOR
Intervention: Objective cough frequency
Number of subjects: 253
Study 32173648 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined medication of risedronate sodium and raloxifene (SERM)
Number of subjects: 0
Study 32173648 — intervention group
Group type: COMPARATOR
Intervention: Risedronate sodium (Control)
Number of subjects: 0
Study 35799266 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel house design
Number of subjects: 0
Study 35799266 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard house design)
Number of subjects: 0
Study 32203109 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle Advice
Number of subjects: 1418
Study 32203109 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 1418
Study 34871577 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist‐supported online remote behavioural intervention
Number of subjects: 201
Study 34871577 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation (control group)
Number of subjects: 201
Study 36171562 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 0.2 mg/kg
Number of subjects: 178
Study 36171562 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 0.25 mg/kg
Number of subjects: 178
Study 36171562 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine 0.3 mg/kg
Number of subjects: 178
Study 36171562 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl 1 μg/kg
Number of subjects: 178
Study 36171562 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 178
Study 33481276 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome (MSQ v2.1 ePRO)
Number of subjects: 2850
Study 32469106 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultural adaptation of motivational interviewing (CAMI)
Number of subjects: 296
Study 32469106 — intervention group
Group type: COMPARATOR
Intervention: Motivational interviewing (MI)
Number of subjects: 296
Study 32469106 — intervention group
Group type: EXPERIMENTAL
Intervention: CAMI with high baseline discrimination
Number of subjects: 296
Study 35797770 — intervention group
Group type: EXPERIMENTAL
Intervention: Subdural Evacuation Port System (SEPS)
Number of subjects: 160
Study 35797770 — intervention group
Group type: COMPARATOR
Intervention: Burr Hole Evacuation (BHE)
Number of subjects: 160
Study 33387508 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal mammary and medial supraclavicular lymph node chain irradiation
Number of subjects: 0
Study 33387508 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 33115278 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1653
Study 33115278 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 1653
Study 34371511 — intervention group
Group type: COMPARATOR
Intervention: Ozil handpiece
Number of subjects: 204
Study 34371511 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Sentry handpiece
Number of subjects: 204
Study 34371511 — intervention group
Group type: EXPERIMENTAL
Intervention: Both handpieces
Number of subjects: 204
Study 33141979 — intervention group
Group type: EXPERIMENTAL
Intervention: AmplifEYE-assisted colonoscopy (AC)
Number of subjects: 334
Study 33141979 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy (SC)
Number of subjects: 334
Study 35147899 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 476
Study 35147899 — intervention group
Group type: COMPARATOR
Intervention: Multidisciplinary Intervention (MDI)
Number of subjects: 476
Study 35147899 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (BI and MDI)
Number of subjects: 476
Study 33596318 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically determined 25(OH)D increase (per 1-SD increase)
Number of subjects: 4662
Study 33596318 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational analysis of plasma 25(OH)D levels
Number of subjects: 4662
Study 33596318 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score for 25(OH)D
Number of subjects: 4662
Study 33596318 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 4662
Study 35112954 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) group
Number of subjects: 101
Study 35112954 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 101
Study 33851360 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral subcapsular orchiectomy (BSO)
Number of subjects: 70
Study 33851360 — intervention group
Group type: COMPARATOR
Intervention: Bilateral extracapsular orchiectomy (BEO)
Number of subjects: 70
Study 33136126 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating
Number of subjects: 0
Study 33136126 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 35838437 — intervention group
Group type: COMPARATOR
Intervention: Repeated assessment (completed surveys at baseline, 3‐, 6‐, and 12‐month follow‐ups)
Number of subjects: 456
Study 35838437 — intervention group
Group type: COMPARATOR
Intervention: Minimal assessment (completed surveys at baseline and 12‐month follow‐up)
Number of subjects: 456
Study 35838437 — intervention group
Group type: COMPARATOR
Intervention: Repeated assessment
Number of subjects: 456
Study 35838437 — intervention group
Group type: COMPARATOR
Intervention: Minimal assessment
Number of subjects: 456
Study 34086751 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU+ABM (Attentional Bias Modification)
Number of subjects: 169
Study 34086751 — intervention group
Group type: COMPARATOR
Intervention: TAU+placebo
Number of subjects: 169
Study 34086751 — intervention group
Group type: COMPARATOR
Intervention: TAU-only
Number of subjects: 169
Study 35510322 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium citrate (CIT) supplementation
Number of subjects: 12
Study 35510322 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 12
Study 35510322 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CIT and PLC
Number of subjects: 12
Study 34960669 — intervention group
Group type: EXPERIMENTAL
Intervention: Selgantolimod (SLGN)
Number of subjects: 0
Study 35089082 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led intervention
Number of subjects: 124
Study 35089082 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 124
Study 34271464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis
Number of subjects: 0
Study 34271464 — intervention group
Group type: EXPERIMENTAL
Intervention: Saponin
Number of subjects: 0
Study 34271464 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-application of Bacillus subtilis and saponin
Number of subjects: 0
Study 34271464 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis and saponin
Number of subjects: 0
Study 33214446 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative hepatic and regional arterial chemotherapy (PHRAC) plus adjuvant therapy
Number of subjects: 688
Study 33214446 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant therapy alone (control)
Number of subjects: 688
Study 33214446 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative hepatic and regional arterial chemotherapy (PHRAC)
Number of subjects: 688
Study 32936427 — intervention group
Group type: EXPERIMENTAL
Intervention: TRZ30 (10 mg three times daily for 8 weeks)
Number of subjects: 141
Study 32936427 — intervention group
Group type: EXPERIMENTAL
Intervention: TRZ60 (20 mg three times daily for 8 weeks)
Number of subjects: 141
Study 32936427 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study 32936427 — intervention group
Group type: COMPARATOR
Intervention: TRZ30 vs Placebo
Number of subjects: 141
Study 36209217 — intervention group
Group type: EXPERIMENTAL
Intervention: Periosteum coverage
Number of subjects: 36
Study 36209217 — intervention group
Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 36
Study 34411045 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual estimation of hypoperfusion
Number of subjects: 122
Study 34411045 — intervention group
Group type: COMPARATOR
Intervention: HipVasc software measurements
Number of subjects: 122
Study 34881669 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week group self-management exercise and education program
Number of subjects: 23
Study 34881669 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 23
Study 33060615 — intervention group
Group type: EXPERIMENTAL
Intervention: Case method learning
Number of subjects: 425
Study 33060615 — intervention group
Group type: COMPARATOR
Intervention: Traditional lectures
Number of subjects: 425
Study 33060615 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 425
Study 33060615 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 425
Study 35101808 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid simulation (standardized patient and task-trainer) in a transport ambulance
Number of subjects: 45
Study 35101808 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-trainer in skill lab
Number of subjects: 45
Study 35101808 — intervention group
Group type: COMPARATOR
Intervention: Control group (no education)
Number of subjects: 45
Study 33458839 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement pattern training (MoveTrain)
Number of subjects: 46
Study 33458839 — intervention group
Group type: COMPARATOR
Intervention: Traditional strength/flexibility (Standard)
Number of subjects: 46
Study 34586927 — intervention group
Group type: EXPERIMENTAL
Intervention: TIGER training (20 minutes) plus 20 minutes of task-specific motor training
Number of subjects: 34
Study 34586927 — intervention group
Group type: COMPARATOR
Intervention: Traditional occupational therapy (20 minutes)
Number of subjects: 34
Study 32101207 — intervention group
Group type: COMPARATOR
Intervention: 0 g RS4
Number of subjects: 31
Study 32101207 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g RS4
Number of subjects: 31
Study 32101207 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g RS4
Number of subjects: 31
Study 33121886 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive sessions
Number of subjects: 53
Study 33121886 — intervention group
Group type: COMPARATOR
Intervention: Traditional lectures
Number of subjects: 53
Study 33239000 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 0
Study 33239000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35222287 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time flash glucose monitoring
Number of subjects: 172
Study 35222287 — intervention group
Group type: COMPARATOR
Intervention: Retrospective flash glucose monitoring
Number of subjects: 172
Study 32653532 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc Blue (RB)
Number of subjects: 28
Study 32653532 — intervention group
Group type: EXPERIMENTAL
Intervention: XP-endo Shaper (XP-S)
Number of subjects: 28
Study 32653532 — intervention group
Group type: EXPERIMENTAL
Intervention: XP-endo Finisher (XP-F)
Number of subjects: 28
Study 34938354 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonate drugs
Number of subjects: 104
Study 34938354 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 104
Study 33051230 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail survey (Group A, n=4999)
Number of subjects: 6999
Study 33051230 — intervention group
Group type: COMPARATOR
Intervention: Web-based survey (Group B, n=2000)
Number of subjects: 6999
Study 33051230 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (mail and web)
Number of subjects: 6999
Study 35236723 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive surveillance (AFB every 6 months)
Number of subjects: 364
Study 35236723 — intervention group
Group type: COMPARATOR
Intervention: Standard surveillance (CT and AFB at 36 months)
Number of subjects: 364
Study 32708737 — intervention group
Group type: EXPERIMENTAL
Intervention: RNA-seq analysis of transcriptional dynamics and identification of key genes involved in grain filling.
Number of subjects: 0
Study 32708737 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation of expression levels of seven randomly selected DEGs by qRT-PCR.
Number of subjects: 0
Study 35432844 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin combined with Traditional Chinese Medicine (TCM) prescription
Number of subjects: 60
Study 35432844 — intervention group
Group type: COMPARATOR
Intervention: Nursing intervention based on control group (Insulin + TCM)
Number of subjects: 60
Study 32798568 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AQ, n = 9)
Number of subjects: 19
Study 32798568 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Exercise + Grape Juice (AQ+GJ, n = 10)
Number of subjects: 19
Study 35240988 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA) during hospital stay
Number of subjects: 155
Study 35240988 — intervention group
Group type: COMPARATOR
Intervention: Care at an ordinary medical hospital ward (Control)
Number of subjects: 155
Study 32007833 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuum model of alcohol problems
Number of subjects: 597
Study 32007833 — intervention group
Group type: COMPARATOR
Intervention: Binary disease model
Number of subjects: 597
Study 32007833 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 597
Study 35471644 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial-based psychosocial intervention (INT) focused on building resilience to stress, improving mental health, and reducing condomless anal sex (CAS). Cost: $49.37/participant.
Number of subjects: 0
Study 35471644 — intervention group
Group type: COMPARATOR
Intervention: Status quo HIV care (SQ)
Number of subjects: 0
Study 33902415 — intervention group
Group type: EXPERIMENTAL
Intervention: RPV/TDF/3TC
Number of subjects: 40
Study 33902415 — intervention group
Group type: COMPARATOR
Intervention: EFV/TDF/3TC
Number of subjects: 40
Study 34823258 — intervention group
Group type: EXPERIMENTAL
Intervention: CADe (Computer-Aided Detection)
Number of subjects: 1076
Study 34823258 — intervention group
Group type: EXPERIMENTAL
Intervention: CAQ (Computer-Aided Quality Improvement)
Number of subjects: 1076
Study 34823258 — intervention group
Group type: EXPERIMENTAL
Intervention: CADe plus CAQ (COMBO)
Number of subjects: 1076
Study 34823258 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1076
Study 33247001 — intervention group
Group type: EXPERIMENTAL
Intervention: e‐coachER (web-based support)
Number of subjects: 450
Study 33247001 — intervention group
Group type: COMPARATOR
Intervention: usual ERS alone (control)
Number of subjects: 450
Study 36247927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazdutide 9 mg (3 mg weeks 1-4; 6 mg weeks 5-8; 9 mg weeks 9-12)
Number of subjects: 24
Study 36247927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazdutide 10 mg (2.5 mg weeks 1-4; 5 mg weeks 5-8; 7.5 mg weeks 9-12; 10 mg weeks 13-16)
Number of subjects: 24
Study 36247927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazdutide
Number of subjects: 24
Study 36247927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 34536445 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest third of heart rate reserve
Number of subjects: 1967
Study 34536445 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest third of heart rate recovery
Number of subjects: 1967
Study 34536445 — intervention group
Group type: COMPARATOR
Intervention: Highest third of heart rate reserve and recovery (control group)
Number of subjects: 1967
Study 34536445 — intervention group
Group type: EXPERIMENTAL
Intervention: Increment in heart rate reserve and recovery
Number of subjects: 1967
Study 616567804 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation exercise
Number of subjects: 282
Study 616567804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 282
Study 33504976 — intervention group
Group type: EXPERIMENTAL
Intervention: Male physicians managing female patients
Number of subjects: 1186
Study 33504976 — intervention group
Group type: EXPERIMENTAL
Intervention: Male physicians managing male patients
Number of subjects: 1186
Study 33504976 — intervention group
Group type: EXPERIMENTAL
Intervention: Female physicians managing female patients
Number of subjects: 1186
Study 33504976 — intervention group
Group type: EXPERIMENTAL
Intervention: Female physicians managing male patients
Number of subjects: 1186
Study 33504976 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall management by male physicians
Number of subjects: 1186
Study 33504976 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall management by male physicians vs female physicians
Number of subjects: 1186
Study 33168910 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouthwash (rinsing, gargling and spraying twice daily for 14 days)
Number of subjects: 12
Study 33168910 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (antibiotics)
Number of subjects: 12
Study 32122273 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine mouth rinse (6 mg/kg)
Number of subjects: 27
Study 32122273 — intervention group
Group type: COMPARATOR
Intervention: Glucose mouth rinse (6.4%)
Number of subjects: 27
Study 32122273 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 27
Study 32122273 — intervention group
Group type: COMPARATOR
Intervention: Ramadan effect
Number of subjects: 27
Study 35643873 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (20 µg/day)
Number of subjects: 183
Study 35643873 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study 35643873 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein yogurt (10 g protein/100 g)
Number of subjects: 183
Study 35643873 — intervention group
Group type: COMPARATOR
Intervention: Normal protein yogurt (3.5 g protein/100 g)
Number of subjects: 183
Study 35643873 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 183
Study 35643873 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-to-stand test
Number of subjects: 183
Study 34350193 — intervention group
Group type: EXPERIMENTAL
Intervention: Proxalutamide 200 mg/day for up to 7 days
Number of subjects: 268
Study 34350193 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 268
Study 35047059 — intervention group
Group type: EXPERIMENTAL
Intervention: Autoimmune cell therapy
Number of subjects: 60
Study 35047059 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 60
Study 34684116 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (cholecalciferol: 2000 IU/day)
Number of subjects: 30